arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

INTELLIGENT BIO SOLUTIONS INC.

INBS
$1.95 ▼ -0.04 (-2.01%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
27 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

INTELLIGENT BIO SOLUTIONS INC. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $3.1M
Dividend Yield
Revenue Growth 17.6%
Op. Margin -277.8%
ROIC -26.0%
FCF / Share $-2.72
Trailing P/E
Price / Book 0.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.06M
↑ +17.6%
Net Income Profit after all expenses
$-2.86M
↓ -12.5%
Operating Margin Operating profit as % of sales
-277.8%
↑ +5.5% 0th
FCF / Share Free cash flow per share
$-2.72
↓ -58.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
0
Cash Quality
62

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 27 quarters